Pharmacokinetic evaluation of ipamorelin and other peptidyl growth hormone secretagogues with emphasis on nasal absorption

References

• AGERHOLM, P. C., BASTHOLM, L., JOHANSEN, P. B., NIELSEN, M. H. and ELLING, F., 1994, Epithelial transport and bioavailability of intranasally administered human growth hormone formulated with the absorption enhancers didecanoyl-L-a-phosphatidylcholine and a-cyclodextrin in rabbits. Journal of Pharmaceutical Sciences, 83, 1706–1711.
   Google Scholar
• BELLONE, J., GHIZZONI, L., AIMARETTI, G., VOLTA, C., BOGHEN, M. F., BERNASCONI, S. and GHIGO, E., 1995, Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature. European Journal of Endocrinology, 133, 425–429.
   PubMed Web of Science ®Google Scholar
• BOWERS, C. Y., CHANG, J., MOMANY, F. and FOLKERS, K., 1977, Effects of the enkephalins and enkephalin analogs on release of pituitary hormones in vitro. In I. MacIntyre (ed.), Molecular Endocrinology (Amsterdam: Elsevier), p 287.
   Google Scholar
• BOWERS, C. Y MOMANY, F. A., REYNOLDS, G. A. and HONG, A., 1984, On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology, 114, 1537–1545.
   PubMed Web of Science ®Google Scholar
• CAMANNI, F., GHIGO, E. and ARVAT, E., 1998, Growth hormone-releasing peptides and their analogs. Frontiers in Neuroendocrinology, 19, 47–72.
   Google Scholar
• CHEN, C. and POLLACK, G. M., 1997, Extensive biliary excretion of the model opoiod peptide [D-PEN'''] Enkephalin in rats. Pharmaceutical Research, 14, 345–350.
   Google Scholar
• DAVIS, C. B., CRYSLER, C. S., BOPPANA, V. K., FONG, K.-L. L., JOSEPH, G. L., URBANSKI, J. J., MACIA, R. A. and RHODES, G. R., 1994, Disposition of growth hormone-releasing peptide (SK&F 110679) in rat and dog following intravenous or subcutaneous administration. Drug Metabolism and Disposition, 22, 90–98.
   Google Scholar
• DUPONT, A., CUSAN, L., GARON, M ALVARADO -URBINA, G. and LABRIE, F., 1977, Extremely rapid degradation of 'II methionine-enkephalin by various rat tissues in vivo and in vitro. Life Sciences, 21, 907–914.
   Google Scholar
• GHIGO, E., ARVAT, E., GIANOTTI, L., ImsimBo, B. P., LENAERTS, V., DEGHENGHI, R. and CAMANNI, F., 1994, Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, intranasal, and oral administration in man. Journal of Clinical Endocrinology and Metabolism, 78, 693–698. GILLESPIE, W. R., 1991, PCDCON v.1.0 (Houston: University of Texas).
   Google Scholar
• GILLESPIE, W. R. and VENG -PEDERSEN, P., 1985, A polyexponential deconvolution method: Evaluation of the gastro-intestinal bioavailability' and mean in vivo dissolution time of some ibuprofen dosage forms. Pharmacokinetics and Biopharmaceutics, 13, 289–307.
   Google Scholar
• GORES, G. J., LARUSSO, N. F. and MILLER, L. J., 1986, Hepatic processing of cholecystokinin peptides. I. Structural specificity and mechanism of hepatic extraction. American Journal of Physiology, 250, G344–349.
   PubMed Web of Science ®Google Scholar
• HARTMAN, M. L., FARELLO, G., PEZZOLI, S. and THORNER, M. 0., 1992, Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men. Journal of Clinical Endocrinology and Metabolism, 74, 1378–1384.
   Google Scholar
• HAYASHI, S., OKIMURA Y YAGI, H., UCHIYAMA, T., TAKESHIMA Y SHAKUTSUI, S., 00HASHI, S., BOWERS, C. Y. and CHIRARA, K., 1991, Intranasal administration of His-D -Trp-A la-Trp-D-Phe-Lys-NH, (growth hormone releasing peptide) increased plasma growth hormone and insulin-like growth factor-1 levels in normal men. Endocrinology Japon, 38, 15–21.
   Google Scholar
• HE1NZEL, G., WOLOSZCZAK, R. and THOMANN, P., 1993, Pharmacokinetic and Pharmacodynamic Data Analysis System for the PC. TOPFIT, 2nd edn (Stuttgart: Gustav Fisher).
   Google Scholar
• HUSSAIN, A. A., HIRAI, S. and BAWARSHI, R., 1980, Nasal absorption of propranolol from different dosage forms by rats and dogs. Journal of Pharmaceutical Sciences, 69, 1411–1413.
   PubMed Web of Science ®Google Scholar
• LARON, Z., FRENKEL, J., GIL -AD, I., KLINGER, B., LUBIN, E., WUTHRICH, P., BOUTIGNIN, F., LENGERTS V. and DEGHENGHI, R., 1994, Growth hormone releasing activity by intranasal administration of a synthetic hexapeptide (hexarelin). Clinical Endocrinology, 41, 539–541.
   Google Scholar
• LARON, Z., FRENKEL J., DEGIIENGHI, R., ANIN S., KLINGER B. and SILBERGELD, A., 1995, Intranasal administration of the GHRP hexarelin accelerates growth in short children. Clinical Endo-crinology, 43, 631–635.
   Google Scholar
• McCoRmicx, G. F., MILLARD, W. J., BADGER, T. M., BOWERS, C. Y. and MARTIN, J. B., 1985, Dose-response characteristics of various peptides with growth hormone releasing activity in the unanesthetized male rat. Endocrinology, 117, 97–105.
   Google Scholar
• MCMARTIN, C, HUTCHINSON, L. E. F., HYDE, R. and PETERS, G. E., 1987, Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity. Journal of Pharmaceutical Sciences, 76, 535–540.
   Google Scholar
• MOMANY, F. A., BOWERS, C. Y., REYNOLDS, G. A., CHANG, D., HONG, A. and NEWLANDER, K., 1984, Conformational energy studies and in vitro and in vivo activity data on growth hormone-releasing peptides. Endocrinology, 114, 1531–1536.
   PubMedGoogle Scholar
• NELSON A. H., WALKER, R. F., CODD, E. E. and BARONA, F. C., 1991, Intranasal activity of the growth hormone releasing peptide His-D-Trp-Ala-Trp-D-Phe-Lys-NH, in conscious dogs. Life Sciences, 48, 2283–2288.
   Google Scholar
• PIHOKER C., MIDDLETON, R., REYNOLDS, G. A., BOWERS, C. Y. and BADGER, T. M., 1995, Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature. Journal of Clinical Endocrinology and Metabolism, 80, 2987–2992.
   Google Scholar
• PONG, S.-S., CHAUNG, L.-Y. P., DEAN, D. C., NARGUND, R. P., PATCHETT, A.A. and SMITH,R. G.,1996, Identification of a new G-protein-linked receptor for growth hormone secretagogues. Molecular Endocrinology, 10, 57–61.
   PubMedGoogle Scholar
• RATIN, K, HANSEN, B. S., JoHANsEN, N. L., THoGERSEN, H., MADSEN, K., ANDERSEN P. H. and ANKERSEN, M., 1998, Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology (in press).
   Google Scholar
• READON, P. M., GocHoco, C. H., AUDUS, K. L., WILSON, G. and SMITH, P. L., 1993, In vitro nasal transport across ovine mucosa: effects of ammonium glycyrrhizinate on electrical properties and permeability of growth hormone releasing peptide, mannitol, and lucifer yellow. Pharmaceutical Research, 10, 553–561.
   Google Scholar
• ROUMI M., MARLEAU, S., BOGHEN M., NILSSON, M., Du SOUICH, P. and ONG, H., 1997, Hepatic extraction of hexarelin, a new peptidic GH secretagogue, in the isolated perfused rat liver. Pharmaceutical Research, 14, 1008–1013.
   Google Scholar
• SARTOR, 0, BOWERS, C. Y., REYNOLDS, G. A. and MOMANY, F. A., 1985, Variables determining the GH response of His-D-Trp-Ala-Trp-D-Phe-Lys-NH,(GHRP-6) in the rat. Endocrinology, 117, 1441–1447.
   Google Scholar
• SMITH, R. G., VAN DER PLOEG, H. A. D., FEIGHNER, S. D., CHENG, K., HICKEY, G. J., WYVRATT, M. J., FISHER, M. H., NARGUND, R. P. and PATCHETT, A. A., 1997, Peptidomimetic regulation of growth hormone secretion. Endocrine Reviews, 18, 621–645.
   Google Scholar
• Su, K. S., CAMPANALE, K. M. and GRIES, C. L., 1984, Nasal drug delivery system of a quaternary ammonium compound. Journal of Pharmaceutical Sciences, 73, 1251–1254.
   PubMed Web of Science ®Google Scholar
• VORA, J. K., CHRISTENSEN, G. A., REGINATO M. J., MACIA, R. A., GOCHOCO, C. H. and OH C. K., 1993, Influence of formulation variables on plasma growth hormone levels following intranasal administration of growth hormone-releasing peptide in anesthetized rats. Journal of Controlled Release, 24, 193–200.
   Google Scholar
• ZIEGLER, K., KOLAC, C., SCHULZE, S., WENZEL, U. and KEMMER, H., 1996, Hepatobiliary elimination of certain peptide-mimicking drugs: linear hydrophobic and hydrophilic renin-inhibitors and hydrophobic cyclopeptides. Journal of Hepatology, 24, 47–52.
   Google Scholar